Literature DB >> 25096657

Acquired von Willebrand's disease associated with epithelial myoepithelial carcinoma of the parotid salivary gland.

Geoffrey Spencer Chilvers1, Graham Porter1.   

Abstract

This is the first case report of a patient with acquired von Willebrand's disease (AvWD) secondary to epithelial myoepithelial carcinoma (EMC) of the parotid salivary gland. This patient presented to haematology following an abnormal bleeding episode with von Willebrand factor Ristocetin cofactor (VWF:RCo) <5% and VWF:Ag 13%. He was diagnosed with AvWD. At the same time he was found to have a left parotid lump which was excised following a multidisciplinary team meeting. This was histologically reported as an EMC. Following excision, unusually this patient's AvWD did not resolve. Extensive investigation looking for other causes of the AvWD did not reveal any other potential cause; therefore, due to the similar timing of onset of both pathologies it is felt that the AvWD in this case is secondary to the EMC. This case report highlights the presentation, investigation and management of AvWD and parotid lumps as well as discussing proposed pathophysiological mechanisms for AvWD. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25096657      PMCID: PMC4127676          DOI: 10.1136/bcr-2014-205248

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  31 in total

Review 1.  Acquired von Willebrand syndrome: from pathophysiology to management.

Authors:  A Veyradier; C S Jenkins; E Fressinaud; D Meyer
Journal:  Thromb Haemost       Date:  2000-08       Impact factor: 5.249

2.  Epithelial-myoepithelial carcinoma of the parotid gland: a case report and review of the cytological and histological features.

Authors:  H Deere; I Hore; N McDermott; T Levine
Journal:  J Laryngol Otol       Date:  2001-05       Impact factor: 1.469

3.  Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulins.

Authors:  A Delmer; M H Horellou; J M Bréchot; J Prudent; F Potevin; C Lecrubier; C Girard-Longhini; M Samama; R Zittoun
Journal:  Am J Hematol       Date:  1992-06       Impact factor: 10.047

4.  Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.

Authors:  Claudia Heilmann; Ulrich Geisen; Friedhelm Beyersdorf; Lea Nakamura; Christoph Benk; Michael Berchtold-Herz; Georg Trummer; Christian Schlensak; Barbara Zieger
Journal:  Thromb Haemost       Date:  2010-03-29       Impact factor: 5.249

Review 5.  Acquired von Willebrand disease.

Authors:  P J van Genderen; J J Michiels
Journal:  Baillieres Clin Haematol       Date:  1998-06

Review 6.  Salivary gland adenocarcinomas: a clinicopathologic analysis of three distinctive types.

Authors:  M A Luna; J G Batsakis; N G Ordóñez; B Mackay; M E Tortoledo
Journal:  Semin Diagn Pathol       Date:  1987-05       Impact factor: 3.464

7.  Acquired von Willebrand syndrome: data from an international registry.

Authors:  A B Federici; J H Rand; P Bucciarelli; U Budde; P J van Genderen; H Mohri; D Meyer; F Rodeghiero; J E Sadler
Journal:  Thromb Haemost       Date:  2000-08       Impact factor: 5.249

8.  Acquired von Willebrand syndrome in a patient with Ewing sarcoma.

Authors:  Murat Elli; Faruk Guclu Pinarli; Ayhan Dagdemir; Nevzat Dabak; Tunc Fisgin; Mustafa Bekir Selcuk; Sevinc Sultansuyu; Sabri Acar
Journal:  Pediatr Hematol Oncol       Date:  2006-03       Impact factor: 1.969

9.  Epithelial-myoepithelial carcinoma of intercalated duct origin. A clinicopathologic and ultrastructural assessment of sixteen cases.

Authors:  R L Corio; J J Sciubba; R B Brannon; J G Batsakis
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1982-03

Review 10.  Major and minor salivary gland tumors.

Authors:  Marco Guzzo; Laura D Locati; Franz J Prott; Gemma Gatta; Mark McGurk; Lisa Licitra
Journal:  Crit Rev Oncol Hematol       Date:  2009-11-24       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.